Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.35% |
| 2 | Energy | 10.93% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Financials | 8.18% |
| 5 | Technology | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXDX
1801
DELISTED
Accelerate Diagnostics
AXDX
| $2.33M | ﹤0.01% |
14,421
+13,093
| +986% | +$2.83M |
|
1802
Hyster-Yale Materials Handling
HY
$576M
| $2.32M | ﹤0.01% |
40,164
+7,428
| +23% | +$474K |
|
|
LHCG
1803
DELISTED
LHC Group LLC
LHCG
| $2.32M | ﹤0.01% |
51,881
+23,910
| +85% | +$1.05M |
|
1804
CALL
Aramark
ARMK
$15B
| $2.32M | ﹤0.01% |
+108,446
| New | +$2.48M |
|
|
ADT
1805
DELISTED
ADT Corp
ADT
| $2.31M | ﹤0.01% |
77,406
-212,873
| -73% | -$6.9M |
|
1806
Coca-Cola Femsa
KOF
$22.5B
| $2.31M | ﹤0.01% |
33,341
+14,826
| +80% | +$1.09M |
|
1807
Southern Copper
SCCO
$138B
| $2.31M | ﹤0.01% |
+93,066
| New | +$2.37M |
|
|
S
1808
PUT
DELISTED
Sprint Corporation
S
| $2.3M | ﹤0.01% |
+600,000
| New | +$2.53M |
|
|
ACHN
1809
DELISTED
Achillion Pharmaceuticals
ACHN
| $2.3M | ﹤0.01% |
+332,229
| New | +$2.71M |
|
1810
CALL
Crown Holdings
CCK
$13B
| $2.29M | ﹤0.01% |
+50,000
| New | +$2.53M |
|
|
ANTH
1811
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $2.29M | ﹤0.01% |
46,957
+40,563
| +634% | +$2.83M |
|
|
SRRA
1812
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $2.28M | ﹤0.01% |
+2,774
| New | +$3.13M |
|
1813
HNI Corp
HNI
$3.08B
| $2.27M | ﹤0.01% |
+52,927
| New | +$2.52M |
|
|
HTS
1814
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $2.27M | ﹤0.01% |
149,523
-226,723
| -60% | -$3.7M |
|
1815
Forrester Research
FORR
$199M
| $2.26M | ﹤0.01% |
72,021
+38,590
| +115% | +$1.27M |
|
1816
Otter Tail
OTTR
$3.81B
| $2.26M | ﹤0.01% |
+86,868
| New | +$2.29M |
|
1817
UnitedHealth
UNH
$382B
| $2.26M | ﹤0.01% |
19,508
-526,962
| -96% | -$63.1M |
|
1818
Cracker Barrel
CBRL
$1.26B
| $2.26M | ﹤0.01% |
15,339
-173,646
| -92% | -$26M |
|
1819
Hancock Whitney
HWC
$6.19B
| $2.26M | ﹤0.01% |
83,483
-970,458
| -92% | -$27.5M |
|
1820
Strategic Education
STRA
$1.98B
| $2.26M | ﹤0.01% |
41,033
+30,793
| +301% | +$1.58M |
|
1821
Fomento Económico Mexicano
FMX
$41.2B
| $2.25M | ﹤0.01% |
+25,199
| New | +$2.24M |
|
|
ADAP
1822
DELISTED
Adaptimmune Therapeutics
ADAP
| $2.25M | ﹤0.01% |
187,823
+70,006
| +59% | +$989K |
|
1823
CALL
Meta Platforms (Facebook)
META
$1.49T
| $2.25M | ﹤0.01% |
+25,000
| New | +$2.29M |
|
|
HEP
1824
DELISTED
Holly Energy Partners, L.P.
HEP
| $2.23M | ﹤0.01% |
+77,000
| New | +$2.4M |
|
|
WPZ
1825
CALL
DELISTED
Williams Partners L.P.
WPZ
| $2.23M | ﹤0.01% |
70,000
-55,000
| -44% | -$2.3M |
|
Similar funds
Millennium Management's Q3 2015 Portfolio in Review
As of Q3 2015, Millennium Management held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Millennium Management deployed $5.12B of net new capital in Q3 2015, opening 840 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 14% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Millennium Management's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Millennium Management added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Millennium Management's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Millennium Management fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Millennium Management's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Millennium Management opened 840 new positions and closed 681 in Q3 2015.
- Millennium Management's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.